ATE49885T1 - Avirulenter rabies-impfstoff. - Google Patents
Avirulenter rabies-impfstoff.Info
- Publication number
- ATE49885T1 ATE49885T1 AT86400780T AT86400780T ATE49885T1 AT E49885 T1 ATE49885 T1 AT E49885T1 AT 86400780 T AT86400780 T AT 86400780T AT 86400780 T AT86400780 T AT 86400780T AT E49885 T1 ATE49885 T1 AT E49885T1
- Authority
- AT
- Austria
- Prior art keywords
- rabies vaccine
- avirulent
- avirulent rabies
- organismes
- france
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8505575A FR2580176B1 (fr) | 1985-04-12 | 1985-04-12 | Vaccin antirabique avirulent |
EP86400780A EP0202142B1 (de) | 1985-04-12 | 1986-04-11 | Avirulenter Rabies-Impfstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE49885T1 true ATE49885T1 (de) | 1990-02-15 |
Family
ID=9318198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86400780T ATE49885T1 (de) | 1985-04-12 | 1986-04-11 | Avirulenter rabies-impfstoff. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0202142B1 (de) |
AT (1) | ATE49885T1 (de) |
DE (1) | DE3668552D1 (de) |
FR (1) | FR2580176B1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2633832B1 (fr) * | 1988-07-05 | 1991-05-31 | Virbac | Vaccin antirabique avirulent |
FR2693655B1 (fr) * | 1992-07-20 | 1994-10-14 | Virbac | Vaccin antirabique avirulent. |
EP1131414B1 (de) * | 1998-11-27 | 2007-03-07 | Intervet International BV | Attenuierte stabile tollwutvirusmutante und lebende impfstoffe |
-
1985
- 1985-04-12 FR FR8505575A patent/FR2580176B1/fr not_active Expired
-
1986
- 1986-04-11 AT AT86400780T patent/ATE49885T1/de not_active IP Right Cessation
- 1986-04-11 EP EP86400780A patent/EP0202142B1/de not_active Expired - Lifetime
- 1986-04-11 DE DE8686400780T patent/DE3668552D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0202142B1 (de) | 1990-01-31 |
DE3668552D1 (de) | 1990-03-08 |
EP0202142A1 (de) | 1986-11-20 |
FR2580176A1 (fr) | 1986-10-17 |
FR2580176B1 (fr) | 1988-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0179139A4 (de) | Leukämieassoziiertes virusimmunogen, impfstoff und testverfahren. | |
IT8621232A0 (it) | Copolimeri silitati dell'isobutilene reticolabili in condizioni ambientali eprocedimento per la loro preparazione. | |
AU6891187A (en) | Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents | |
ATE77653T1 (de) | Antibiotikum hergestellt von lysobacter sp. sc 14,067. | |
NL960005I2 (nl) | Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan. | |
FI945626A (fi) | Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi | |
AU1631188A (en) | Newcastle disease virus vaccine and method for the application thereof | |
DE3585578D1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
DE3668552D1 (de) | Avirulenter rabies-impfstoff. | |
AU7890687A (en) | DNA sequence vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of multiplying in CHO cells | |
DE3888887D1 (de) | Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung. | |
ES506116A0 (es) | Procedimiento para la obtencion de isomaltulosa a partir de sacarosa | |
DE68918649D1 (de) | Lebende Newcastle-Krankheit-Virus-Vakzine. | |
IT1218692B (it) | Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione | |
DK642687A (da) | N,n'-disubstituerede urinstoffer samt fremgangsmaade til fremstilling deraf | |
AU591290B2 (en) | Rapid detection of n. gonorrhoeae without culture | |
ATE51894T1 (de) | Spezifische mycoplasma-membran-antigene und antik¯rper sowie deren klinische verwendungen. | |
IT8620026A0 (it) | Tripeptide ad attivita'immunostimolante. | |
IT8622348A0 (it) | 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione. | |
DE69008400T2 (de) | Herstellung von 2-Desoxyuridin. | |
SU877368A1 (ru) | Способ измерени силы | |
IT8720060A0 (it) | Perfluoro 2,3,4-trimetilpentano eprocedimento per la sua preparazione. | |
AU7638287A (en) | Improved mutant vaccinia virus and process for production thereof | |
EP0345559A3 (de) | HIV-2-Varianten | |
UA6146A1 (uk) | 1,1-біс-[2-(2,7-діацетоксифлуорениліден-9-гідразоно)тиазолідон-4-іл-5]-о-нітрофенилметан, що виявляє антивірусну дію відносно рнк- та днк- вмістних вірусів |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |